Rhinomed presentation August 2014
Michael Johnson has been CEO of Rhinomed (RNO) for the past 18 months.
RNO is a medical technology company with a focus on nasal respiratory and breathing management.
Michael presented to the Morgans network on Tuesday, 5 August 2014, providing insight into the company's key products and growth prospects.
You can watch the presentation below:
Michael Johnson, Rhinomed (RNO)
If you are interested in finding out more about Rhinomed (RNO), please contact your adviser or nearest Morgans office.
Our research is complimentary for all Morgans clients. Contact us if you are interested in becoming a client and accessing our research.